Jaguar Health closes $350K private placement of 6% notes and warrants for working capital

Jaguar Health, Inc.

Issued $350K aggregate principal of 6% unsecured promissory notes to accredited investors on Jan 6, 2026.
Notes mature one month from issuance; prepayable without penalty.
Investors received warrants to purchase up to 350K shares at $1.00/share, exercisable for 5 years.
Proceeds used for working capital and general corporate purposes.
Amendment corrects execution and closing dates in original 8-K from Jan 6 to Jan 6 (scrivener's error).

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Jaguar Health, Inc. incurred senior notes of $350,000 at 6% per annum maturing one month after issuance.

Instrument: senior notes
Principal: $350,000
Rate: 6% per annum
Maturity: one month after issuance
Event: incurrence

Exact text from the filing

On January 6, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 aggregate principal amount (effective 2026-01-06).

Action: entry
Agreement: equity purchase
Counterparty: two accredited investors
Value: $350,000 aggregate principal amount
Effective: 2026-01-06

Exact text from the filing

On January 6, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the "Notes") to such Investors.

View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-009644

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.